Patent ID: 6323214
Filing Date: 2001-11-27
Classification: A61K,A61P,C07D

Abstract:
A method for providing cardioprotection, neuroprotection, pain management, reduction of free fatty acids, triglycerides, or glucose levels, adjunct therapy in diabetes, treatment of GI disorders, treatment of glaucoma; treatment of sleep disorders; treatment of cardiac disarrythmias (peroxysmal supraventricular tachycardia), treatment of congestive heart failure or treatment of inflammation comprising administering to a patient in need of treatment thereof an effective amount to treat the disorder of a compound selected from a group consisting of compounds of formulas: ##STR9##wherein:R.sub.1 is hydrogen, alkyl, substituted alkyl, or haloacetyl;R.sub.2, R.sub.3, and R.sub.4 are independently hydrogen, halogen, alkyl, substituted alkyl, aryl, heteroaryl, heterocyclic, lower alkenyl, lower alkanoyl, amino, trifluoromethyl, amino alkyl, nitro, or cyano.